← Leaderboards
Samuel Klein
Washington University
$33,055,933
Attributed
$42,509,856
Total exposure
57
Grants
38
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,244,965 · 58
By mechanism
P30$35,714,611 · 9
R01$21,499,580 · 9
U01$5,343,499 · 1
R44$2,980,940 · 1
R42$1,653,666 · 1
M01$1,063,206 · 28
Top collaborators
- Debra Haire-Joshu11 shared
- Bettina Mittendorfer10 shared
- Alison G Cahill7 shared
- Kelle H Moley4 shared
- Dmitri Samovski3 shared
- Dung L Thai3 shared
- Dung "Zung" Thai3 shared
Most similar at Washington University
Same institution · by research overlap
- Bettina Mittendorfer$14,806,767
- Peter A Crawford$19,489,388
- David R Piwnica-Worms$22,122,563
- Robert J Gropler$22,166,148
- Jeffrey Ivan Gordon$32,802,915
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityMetabolicClinical ResearchAdipose TissueResearch PersonnelInsulin ResistanceBaseFundingServicesInsulinInsulin SensitivityUniversitiesWashingtonPlasmaGrantTracerHuman SubjectDiabetes MellitusLiverNutritionFunctional DisorderDietBody CompositionMuscle
Grant awards (200)
Exosomes and insulin action in metabolically healthy and unhealthy obesity$663,670
R01 · FY2025 · DK · contact PI
EFFICACY AND SAFETY OF A KETOGENIC DIET IN TYPE 1 DIABETES$628,553
R01 · FY2025 · DK · contact PI
Administrative Core$252,190
P30 · FY2025 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,181,250
P30 · FY2024 · DK · contact PI
EFFICACY AND SAFETY OF A KETOGENIC DIET IN TYPE 1 DIABETES$641,303
R01 · FY2024 · DK · contact PI
Exosomes and insulin action in metabolically healthy and unhealthy obesity$590,157
R01 · FY2024 · DK · contact PI
NAD+ and metabolic flexibility$415,320
R01 · FY2024 · DK · contact PI
Administrative Core$243,848
P30 · FY2024 · DK · contact PI
NAD+ and metabolic flexibility$59,881
R01 · FY2024 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,181,250
P30 · FY2023 · DK · contact PI
Exosomes and insulin action in metabolically healthy and unhealthy obesity$573,795
R01 · FY2023 · DK · contact PI
Animal and plant proteins and glucose metabolism$568,019
R01 · FY2023 · DK · contact PI
NAD+ and metabolic flexibility$393,750
R01 · FY2023 · DK · contact PI
Administrative Core$252,190
P30 · FY2023 · DK · contact PI
NAD+ and metabolic flexibility$90,401
R01 · FY2023 · DK · contact PI
NAD+ and metabolic flexibility$19,438
R01 · FY2023 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,181,250
P30 · FY2022 · DK · contact PI
Metabolic Effects of Sleep Extension in People with Obesity$607,680
R01 · FY2022 · DK · contact PI
Animal and plant proteins and glucose metabolism$568,019
R01 · FY2022 · DK
NAD+ and metabolic flexibility$393,750
R01 · FY2022 · DK · contact PI
Administrative Core$252,190
P30 · FY2022 · DK · contact PI
NAD+ and metabolic flexibility$30,327
R01 · FY2022 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,181,250
P30 · FY2021 · DK · contact PI
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,807
R44 · FY2021 · DK
Metabolic Effects of Sleep Extension in People with Obesity$607,680
R01 · FY2021 · DK · contact PI
Animal and plant proteins and glucose metabolism$568,019
R01 · FY2021 · DK
NAD+ and metabolic flexibility$393,750
R01 · FY2021 · DK · contact PI
Administrative Core$252,190
P30 · FY2021 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,143,750
P30 · FY2020 · DK · contact PI
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,807
R44 · FY2020 · DK
Metabolic Effects of Sleep Extension in People with Obesity$588,413
R01 · FY2020 · DK · contact PI
Animal and plant proteins and glucose metabolism$567,568
R01 · FY2020 · DK
Administrative Core$215,563
P30 · FY2020 · DK · contact PI
Washington University Nutrition Obesity Research Center$150,041
P30 · FY2020 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,143,750
P30 · FY2019 · DK · contact PI
Assessment of Multiple Dose Administration of Glucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,326
R44 · FY2019 · DK
Metabolic Effects of Sleep Extension in People with Obesity$595,451
R01 · FY2019 · DK · contact PI
Animal and plant proteins and glucose metabolism$552,499
R01 · FY2019 · DK
Administrative Core$215,563
P30 · FY2019 · DK · contact PI
Washington University Nutrition Obesity Research Center$152,992
P30 · FY2019 · DK · contact PI
Administrative Core$152,992
P30 · FY2019 · DK · contact PI
Washington University Nutrition Obesity Research Center$51,291
P30 · FY2019 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,143,750
P30 · FY2018 · DK · contact PI
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$680,901
R42 · FY2018 · DK · contact PI
Metabolic Effects of Sleep Extension in People with Obesity$536,357
R01 · FY2018 · DK · contact PI
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$487,314
R01 · FY2018 · DK · contact PI
Administrative Core$215,563
P30 · FY2018 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,143,750
P30 · FY2017 · DK · contact PI
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$748,101
R42 · FY2017 · DK · contact PI
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$487,314
R01 · FY2017 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$248,253
U01 · FY2017 · DK · contact PI
Administrative Core$215,564
P30 · FY2017 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,143,750
P30 · FY2016 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$844,762
U01 · FY2016 · DK · contact PI
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$527,397
R01 · FY2016 · DK · contact PI
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$224,664
R42 · FY2016 · DK · contact PI
Administrative Core$215,563
P30 · FY2016 · DK · contact PI
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$58,587
R01 · FY2016 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,109,866
P30 · FY2015 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$742,176
U01 · FY2015 · DK · contact PI
CALORIE RESTRICTION AND METABOLIC HEALTH$503,307
R01 · FY2015 · DK
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$487,314
R01 · FY2015 · DK · contact PI
Administrative Core$426,240
P30 · FY2015 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$240,001
U01 · FY2015 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,104,237
P30 · FY2014 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$729,138
U01 · FY2014 · DK · contact PI
CALORIE RESTRICTION AND METABOLIC HEALTH$503,307
R01 · FY2014 · DK
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES$487,314
R01 · FY2014 · DK · contact PI
Administrative Core$425,111
P30 · FY2014 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$120,001
U01 · FY2014 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,044,854
P30 · FY2013 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$723,950
U01 · FY2013 · DK · contact PI
CALORIE RESTRICTION AND METABOLIC HEALTH$485,693
R01 · FY2013 · DK
Administrative Core$324,447
P30 · FY2013 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,109,866
P30 · FY2012 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$745,359
U01 · FY2012 · DK · contact PI
CALORIE RESTRICTION AND METABOLIC HEALTH$503,307
R01 · FY2012 · DK
METABOLICALLY NORMAL AND ABNORMAL OBESITY$433,556
R01 · FY2012 · DK · contact PI
Administrative Core$426,238
P30 · FY2012 · DK · contact PI
EFFECTS OF BARIATRIC SURGERY ON GLUCOSE HOMEOSTASIS IN TYPE-2 DIABETES$190,000
R03 · FY2012 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$50,000
U01 · FY2012 · DK · contact PI
Washington University Nutrition Obesity Research Center$1,109,866
P30 · FY2011 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$759,976
U01 · FY2011 · DK · contact PI
CALORIE RESTRICTION AND METABOLIC HEALTH$501,214
R01 · FY2011 · DK
METABOLICALLY NORMAL AND ABNORMAL OBESITY$433,559
R01 · FY2011 · DK · contact PI
Administrative Core$426,238
P30 · FY2011 · DK · contact PI
Weight Management in Obese Pregnant Underserved African American Women$139,883
U01 · FY2011 · DK · contact PI
EFFECT OF VISCERAL FAT ON INSULIN SENSITIVITY$17,372
P51 · FY2011 · RR · contact PI
Washington University Clinical Nutrition Research Unit$1,140,000
P30 · FY2010 · DK · contact PI
CSR Core$478,126
P30 · FY2010 · DK · contact PI
METABOLICALLY NORMAL AND ABNORMAL OBESITY$442,695
R01 · FY2010 · DK · contact PI
AMR Core$276,949
P30 · FY2010 · DK · contact PI
BMA Core$205,082
P30 · FY2010 · DK · contact PI
Adipocyte Biology Core$179,843
P30 · FY2010 · DK · contact PI
Clinical Science Service Core$72,561
P50 · FY2010 · HL · contact PI
EFFECT OF VISCERAL FAT ON INSULIN SENSITIVITY$29,848
P51 · FY2010 · RR · contact PI
Washington University Clinical Nutrition Research Unit$1,059,604
P30 · FY2009 · DK · contact PI
CSR Core$485,929
P30 · FY2009 · DK · contact PI
Washington University Clinical Nutrition Research Unit$300,000
P30 · FY2009 · DK · contact PI
AMR Core$281,469
P30 · FY2009 · DK · contact PI
BMA Core$208,429
P30 · FY2009 · DK · contact PI
Adipocyte Biology Core$182,777
P30 · FY2009 · DK · contact PI
Washington University Clinical Nutrition Research Unit$99,000
P30 · FY2009 · DK · contact PI
Clinical Science Service Core$74,126
P50 · FY2009 · HL · contact PI
Washington University Clinical Nutrition Research Unit$1,059,604
P30 · FY2008 · DK · contact PI
CSR Core$465,374
P30 · FY2008 · DK · contact PI
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$430,721
R01 · FY2008 · DK · contact PI
AMR Core$269,564
P30 · FY2008 · DK · contact PI
BMA Core$199,619
P30 · FY2008 · DK · contact PI
Adipocyte Biology Core$175,047
P30 · FY2008 · DK · contact PI
Clinical Science Service Core$76,909
P50 · FY2008 · HL · contact PI
Washington University Clinical Nutrition Research Unit$50,000
P30 · FY2008 · DK · contact PI
EFFECTS OF OMENTECTOMY ON LIPID METABOLISM$2,347
P51 · FY2008 · RR · contact PI
Washington University Clinical Nutrition Research Unit$1,059,604
P30 · FY2007 · DK · contact PI
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$559,654
R01 · FY2007 · DK · contact PI
Core A$459,978
P30 · FY2007 · DK · contact PI
CSR Core$251,492
P30 · FY2007 · DK · contact PI
AMR Core$145,671
P30 · FY2007 · DK · contact PI
BMA Core$107,869
P30 · FY2007 · DK · contact PI
Clinical Science Service Core$103,488
P50 · FY2007 · HL · contact PI
Adipocyte Biology Core$94,594
P30 · FY2007 · DK · contact PI
PATHOPHYSIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN OBESITY$42,834
M01 · FY2007 · RR · contact PI
EFFECTS OF OMENTECTOMY ON LIPID METABOLISM$26,264
P51 · FY2007 · RR · contact PI
DIABETES, DIET AND CARDIOVASCULAR RISK$15,995
M01 · FY2007 · RR · contact PI
EXERCISE DOSE AND NON-ALCOHOLIC FATTY LIVER DISEASE$12,471
M01 · FY2007 · RR · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE IN OVERWEIGHT ADOLESCENTS$9,895
M01 · FY2007 · RR · contact PI
LOW VS HIGH CARBOHYDRATE DIETS$8,946
M01 · FY2007 · RR · contact PI
METABOLIC AND ANTIOXIDANT EFFECTS OF URIC ACID IN OBESITY$4,609
M01 · FY2007 · RR · contact PI
GASTRIC BYPASS SURGERY IMPROVES METABOLIC AND HEPATIC ABNORMALITIES$2,824
P41 · FY2007 · RR · contact PI
Washington University Clinical Nutrition Research Unit$1,168,034
P30 · FY2006 · DK · contact PI
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$426,654
R01 · FY2006 · DK · contact PI
PATHOPHYSIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN OBESITY$172,840
M01 · FY2006 · RR · contact PI
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$132,156
R01 · FY2006 · DK · contact PI
Clinical Science Service Core$106,253
P50 · FY2006 · HL · contact PI
DIABETES, DIET AND CARDIOVASCULAR RISK$84,547
M01 · FY2006 · RR · contact PI
LOW VS HIGH CARBOHYDRATE DIETS$72,052
M01 · FY2006 · RR · contact PI
Nutrition-Behavioral Cardiovascular Disease Prevention$56,245
T32 · FY2006 · HL · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE IN OVERWEIGHT ADOLESCENTS$12,911
M01 · FY2006 · RR · contact PI
METABOLIC EFFECTS OF ANOREXIA NERVOSA$5,414
M01 · FY2006 · RR · contact PI
LEPTIN AND INSULIN RESISTANCE$2,499
M01 · FY2006 · RR · contact PI
WEIGHT LOSS & PHYSICAL TRAINING & MUSCULOSKELETAL STATUS IN OBESE ELDERLY$433
M01 · FY2006 · RR · contact PI
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$472,500
P30 · FY2005 · DK
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$424,200
R01 · FY2005 · DK
LOW VS HIGH CARBOHYDRATE DIETS$196,759
M01 · FY2005 · RR
Nutrition-Behavioral Cardiovascular Disease Prevention$161,073
T32 · FY2005 · HL
EXERCISE AS PREVENTIVE MEDICINE IN THE AGING PROCESS$70,153
T32 · FY2005 · AG
DIABETES, DIET AND CARDIOVASCULAR RISK$60,383
M01 · FY2005 · RR
PATHOPHYSIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN OBESITY$36,969
M01 · FY2005 · RR
FOOD ASPIRATION THERAPY ON OBESITY$22,592
M01 · FY2005 · RR
NON-ALCOHOLIC FATTY LIVER DISEASE AND OBESITY$17,663
M01 · FY2005 · RR
VERY LOW DENSITY LIPOPROTEIN METABOLISM IN PATIENTS WITH END-STAGE RENAL DISEASE$12,733
M01 · FY2005 · RR
WEIGHT LOSS &PHYSICAL TRAINING &MUSCULOSKELETAL STATUS IN OBESE ELDERLY$9,858
M01 · FY2005 · RR
EFFECTIVENESS OF THE ATKINS DIET FOR WEIGHT LOSS - FOLLOW UP STUDY$8,216
M01 · FY2005 · RR
LIPOSUCTION ON INSULIN SENSITIVITY, BODY COMPOSITION, &ADIPOCYTE METABOLISM$3,697
M01 · FY2005 · RR
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$810,000
P30 · FY2004 · DK
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE$411,845
R01 · FY2004 · DK
ADIPOSE TISSUE METABOLISM IN HAART$308,000
R01 · FY2004 · DK
Low vs. High Carbohydrate Diets$105,073
M01 · FY2004 · RR
Non-Alcoholic Fatty Liver Disease and Obesity$45,989
M01 · FY2004 · RR
Liposuction on Insulin Sensitivity, Body Composition, &Adipocyte Metabolism$21,717
M01 · FY2004 · RR
Effect of Dietary Fiber on Colonic Mucosa Metabolism$19,481
M01 · FY2004 · RR
Diabetes, Diet and Cardiovascular Risk$16,927
M01 · FY2004 · RR
Weight Loss &Physical Training &Musculoskeletal Status in Obese Elderly$15,969
M01 · FY2004 · RR
Very Low Density Lipoprotein Metabolism in Patients with End-Stage Renal Disease$15,011
M01 · FY2004 · RR
Food Aspiration Therapy on Obesity$7,984
M01 · FY2004 · RR
Adipose Tissue Metabolism in HAART$739
M01 · FY2004 · RR
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$810,000
P30 · FY2003 · DK
ADIPOSE TISSUE METABOLISM IN HAART$308,000
R01 · FY2003 · DK
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$810,000
P30 · FY2002 · DK
ADIPOSE TISSUE METABOLISM IN HAART$308,000
R01 · FY2002 · DK
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE MAN$294,751
R01 · FY2002 · DK
ADIPOSE TISSUE METABOLISM IN HAART$20,800
R01 · FY2002 · DK
R METHU FC LEPTIN/R METHULEPTIN ON GLUCOSE AND LIPID METABOLISM IN NIDDM$0
M01 · FY2002 · RR
REGULATION OF TRIACYLGLYCEROL METABOLISM IN OBESITY$0
M01 · FY2002 · RR
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE$0
M01 · FY2002 · RR
EXERCISE AND LIPID METABOLISM IN OBESE WOMEN$0
M01 · FY2002 · RR
52 WEEK ORLISTAT TREATMENT IN OBESE PATIENTS$0
M01 · FY2002 · RR
TROGLITAZONE ON SUBSTRATE METABOLISM AND BODY COMPOSITION IN DIABETES$0
M01 · FY2002 · RR
RECYCLING OF UREA NITROGEN IN CANCER$0
M01 · FY2002 · RR
WEIGHT REDUCTION AND EXERCISE TRAINING IN OBESITY$0
M01 · FY2002 · RR
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$810,000
P30 · FY2001 · DK
ADIPOSE TISSUE METABOLISM IN HAART$308,334
R01 · FY2001 · DK
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE MAN$288,452
R01 · FY2001 · DK
EXERCISE AND LIPID METABOLISM IN OBESE WOMEN$0
M01 · FY2001 · RR
52 WEEK ORLISTAT TREATMENT IN OBESE PATIENTS$0
M01 · FY2001 · RR
R METHU FC LEPTIN/R METHULEPTIN ON GLUCOSE AND LIPID METABOLISM IN NIDDM$0
M01 · FY2001 · RR
TROGLITAZONE ON SUBSTRATE METABOLISM AND BODY COMPOSITION IN DIABETES$0
M01 · FY2001 · RR
RECYCLING OF UREA NITROGEN IN CANCER$0
M01 · FY2001 · RR
WEIGHT REDUCTION AND EXERCISE TRAINING IN OBESITY$0
M01 · FY2001 · RR
REGULATION OF TRIACYLGLYCEROL METABOLISM IN OBESITY$0
M01 · FY2001 · RR
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE$0
M01 · FY2001 · RR
WASHINGTON UNIVERSITY CLINICAL NUTRITION RESEARCH UNIT$810,000
P30 · FY2000 · DK
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE MAN$282,335
R01 · FY2000 · DK
THERMOGENESIS AND EXERCISE IN LEAN AND OBESE$0
M01 · FY2000 · RR
EXERCISE AND LIPID METABOLISM IN OBESE WOMEN$0
M01 · FY2000 · RR
52 WEEK ORLISTAT TREATMENT IN OBESE PATIENTS$0
M01 · FY2000 · RR
R METHU FC LEPTIN/R METHULEPTIN ON GLUCOSE AND LIPID METABOLISM IN NIDDM$0
M01 · FY2000 · RR
TROGLITAZONE ON SUBSTRATE METABOLISM AND BODY COMPOSITION IN DIABETES$0
M01 · FY2000 · RR
RECYCLING OF UREA NITROGEN IN CANCER$0
M01 · FY2000 · RR
WEIGHT REDUCTION AND EXERCISE TRAINING IN OBESITY$0
M01 · FY2000 · RR